FDA
approval
· 2018-01-25
FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
Summary
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP, resulting in updated labeling for HIV-1 infection treatme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PREZISTA (DARUNAVIR)